Search Page

1

Cite

Share

Challenges in the Design and Interpretation of Noninferiority Trials.

Mauri L, D'Agostino RB Sr. Mauri L, et al. N Engl J Med. 2017 Oct 5;377(14):1357-1367. doi: 10.1056/NEJMra1510063. N Engl J Med. 2017. PMID: 28976859 Review. No abstract available.

Cite

Share

2

Cite

Share

Bioresorbable polymer drug-eluting stents - Authors' reply.

Kandzari DE, Mauri L, Koolen JJ, Doros G, Waksman R. Kandzari DE, et al. Among authors: mauri l. Lancet. 2018 Mar 10;391(10124):936-937. doi: 10.1016/S0140-6736(18)30535-X. Lancet. 2018. PMID: 29536855 No abstract available.

Cite

Share

3

Cite

Share

Design and rationale of a randomized noninferiority trial to evaluate the SurVeil drug-coated balloon in subjects with stenotic lesions of the femoropopliteal artery - the TRANSCEND study.

Elmariah S, Ansel GM, Brodmann M, Doros G, Fuller S, Gray WA, Pinto DS, Rosenfield KA, Mauri L. Elmariah S, et al. Among authors: mauri l. Am Heart J. 2019 Mar;209:88-96. doi: 10.1016/j.ahj.2018.12.012. Epub 2018 Dec 28. Am Heart J. 2019. PMID: 30685679 Clinical Trial.

Cite

Share

4

Cite

Share

Renal Denervation: Where to Now?

Wimmer NJ, Mauri L. Wimmer NJ, et al. Among authors: mauri l. Curr Cardiol Rep. 2015 Dec;17(12):116. doi: 10.1007/s11886-015-0675-8. Curr Cardiol Rep. 2015. PMID: 26482759 Review.

Cite

Share

5

Cite

Share

Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right.

Weber MA, Kirtane A, Mauri L, Townsend RR, Kandzari DE, Leon MB. Weber MA, et al. Among authors: mauri l. J Clin Hypertens (Greenwich). 2015 Oct;17(10):743-50. doi: 10.1111/jch.12590. Epub 2015 May 14. J Clin Hypertens (Greenwich). 2015. PMID: 25973584 No abstract available.

Cite

Share

6

Cite

Share

Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.

Udell JA, Bonaca MP, Collet JP, Lincoff AM, Kereiakes DJ, Costa F, Lee CW, Mauri L, Valgimigli M, Park SJ, Montalescot G, Sabatine MS, Braunwald E, Bhatt DL. Udell JA, et al. Among authors: mauri l. Eur Heart J. 2016 Jan 21;37(4):390-9. doi: 10.1093/eurheartj/ehv443. Epub 2015 Aug 31. Eur Heart J. 2016. PMID: 26324537 Review.

Cite

Share

7

Cite

Share

Renal denervation for the treatment of hypertension: Making a new start, getting it right.

Weber MA, Kirtane A, Mauri L, Townsend RR, Kandzari DE, Leon MB. Weber MA, et al. Among authors: mauri l. Catheter Cardiovasc Interv. 2015 Nov;86(5):855-63. doi: 10.1002/ccd.26028. Epub 2015 Jun 11. Catheter Cardiovasc Interv. 2015. PMID: 26097069

Cite

Share

8

Cite

Share

Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.

Elmariah S, Mauri L, Doros G, Galper BZ, O'Neill KE, Steg PG, Kereiakes DJ, Yeh RW. Elmariah S, et al. Among authors: mauri l. Lancet. 2015 Feb 28;385(9970):792-8. doi: 10.1016/S0140-6736(14)62052-3. Epub 2014 Nov 16. Lancet. 2015. PMID: 25467565 Free PMC article. Review.

Cite

Share

9

Cite

Share

Noninferiority Trials.

Mauri L, D’Agostino RB Sr. Mauri L, et al. N Engl J Med. 2018 Jan 18;378(3):304-305. doi: 10.1056/NEJMc1714668. N Engl J Med. 2018. PMID: 29342382 No abstract available.

Cite

Share

10

Cite

Share

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, Solomon SD, Marler JR, Teerlink JR, Farb A, Morrow DA, Targum SL, Sila CA, Thanh Hai MT, Jaff MR, Joffe HV, Cutlip DE, Desai AS, Lewis EF, Gibson CM, Landray MJ, Lincoff AM, White CJ, Brooks SS, Rosenfield K, Domanski MJ, Lansky AJ, McMurray JJV, Tcheng JE, Steinhubl SR, Burton P, Mauri L, O'Connor CM, Pfeffer MA, Hung HMJ, Stockbridge NL, Chaitman BR, Temple RJ; Standardized Data Collection for Cardiovascular Trials Initiative (SCTI). Hicks KA, et al. Among authors: mauri l. J Am Coll Cardiol. 2018 Mar 6;71(9):1021-1034. doi: 10.1016/j.jacc.2017.12.048. J Am Coll Cardiol. 2018. PMID: 29495982 Review.

Cite

Share